Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial - Concepedia

Concepedia

Publication | Open Access

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial

DOI Full Paper Access

112

Citations

25

References

2019

Year

Peter Vink, Ignacio Delgado Mingorance, C. Maximiano Alonso, Belén Rubio‐Viqueira, Kyung Hae Jung, Juan F. Rodríguez-Moreno, Enrique Grande, David Marrupe, Sarah Lowndes, Javier Puente,

Abstract

RZV was immunogenic in patients with STs receiving immunosuppressive chemotherapies. Humoral and cell-mediated immune responses persisted 1 year after vaccination. No safety concerns were identified.

References

	Year	Citations

Page 1